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Abstract
Background: Asparagine synthetase deficiency (OMIM# 615574) is a very rare newly described neurometabolic
disorder characterized by congenital microcephaly and severe global developmental delay, associated with intractable
seizures or hyperekplexia. Brain MRI typically shows cerebral atrophy with simplified gyral pattern and delayed
myelination. Only 12 cases have been described to date. The disease is caused by homozygous or compound
heterozygous mutations in the ASNS gene on chromosome 7q21.
Case presentation: Family 1 is a multiplex consanguineous family with five affected members, while Family 2 is
simplex. One affected from each family was available for detailed phenotyping. Both patients (Patients 1 and 2)
presented at birth with microcephaly and severe hyperekplexia, and were found to have gross brain malformation
characterized by simplified gyral pattern, and hypoplastic cerebellum and pons. EEG showed no epileptiform discharge
in Patient 2 but multifocal discharges in patient 1. Patient 2 is currently four years old with severe neurodevelopmental
delay, quadriplegia and cortical blindness. Whole exome sequencing (WES) revealed a novel homozygous mutation in
ASNS (NM_001178076.1) in each patient (c.970C > T:p.(Arg324*) and c.944A > G:p.(Tyr315Cys)).
Conclusion: Our results expand the mutational spectrum of the recently described asparagine synthetase deficiency
and show a remarkable clinical homogeneity among affected individuals, which should facilitate its recognition and
molecular confirmation for pertinent and timely genetic counseling.
Keywords: Hyperekplexia, Brain malformation, Asparagine synthetase deficiency, ASNS gene, Whole exome
sequencing, Arthrogryposis, Case report
Background
Asparagine synthetase deficiency (ASNSD, OMIM#
615574) is a very rare newly described autosomal recessive
neurometabolic disorder, caused by homozygous or com-
pound heterozygous mutations in the ASNS gene on
chromosome 7q21 [1]. The phenotype is characterized by
microcephaly, severely delayed psychomotor development,
progressive encephalopathy, cortical atrophy with reduced
cerebral volume and enlarged lateral ventricles (associated
in some with cerebellar and pontine hypoplasia, simplified
gyral pattern, cortical dysgenesis and delayed myelination),
intractable seizures or hyperekplexic activity, appendicular
hypertonia and hyperreflexia [1]. Other associated features
include micrognathia, receding forehead, relatively large
ears, axial hypotonia and cortical blindness.
To the best of our knowledge, only 12 patients were
described in the literature including the nine original pa-
tients reported by Ruzzo et al. [1] from four families of
Iranian Jewish, French Canadian, and Bangladeshi ori-
gins, two of whom were consanguineous. Two patients
were subsequently reported by Alfadhel et al. [2] from
Saudi Arabia, and another reported by Ben-Salem et al.
[3] from United Arab Emirates, all born to consanguin-
eous parents (Table 1).
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In this report, we describe two additional cases from
Saudi Arabia belonging to two consanguineous families,
with typical clinical and radiological features of ASNSD.
The diagnosis was confirmed by whole exome sequencing
(WES), which revealed two novel mutations in the ASNS
gene. This is the fourth ASNSD report in the literature.
Case presentation
Patient 1
The proband (Fig. 1, V: 2) is 1-month-old Saudi boy born
normally at term to first 24-year- old parents. Four mater-
nal aunts (Fig. 1, IV: 1, 4, 7, 8.) had died at the age of four,
five, three and six weeks respectively, in a remote med-
ical facility with no available records. However, all are
said to have presented with microcephaly and abnormal
movements similar to the index (see below). The mother
was G2P1 (IUFD at 28 weeks gestation) +0. No history of
exposures. Antenatal ultrasound (US) scan showed micro-
cephaly. Apgar score was 9 and 10 at one and five mi-
nutes, respectively. Birth weight 2675gm (10th percentile),
head circumference 29 cm (−3SD). Examination showed
microcephaly, sloping forehead, short neck, and micro-
gnathia (Fig. 2a). Shortly after birth, he developed abnor-
mal movements in the form of bursts of tonic/clonic
movements provoked by non-habituating glabellar and
root of the nose tapping, sound and light (see Additional
files 1, 2 and 3). There was hyperreflexia, hypertonia and
arthrogryposis of the lower limbs. He developed frequent
apneas necessitating mechanical ventilation. Treatment
with clonazepam was initiated and later phenobarbitone
Table 1 Clinical features of cases with asparagine synthetase deficiency due to ASNS gene mutation
Present report Ruzzo et al. [1] Ben Salem et al. [3] Alfadhel et al. [2]
Patient 1 Patient 2
Number of pts 2 9 1 2
Number of families 2 4 1 1
Age 1 month 4 Yrs 9 month–14 Yrs 5 Yrs 2 Yrs/4 Yrs
Gender M M 8M/1F M 1M/1F
Ethnic origin Arab Arab Iranian Jews, French Arab Arab
Canadian, Bangladeshi
Consanguinity Yes Yes Yes in two families Yes Yes
Mutation in
ASNS gene
c.1219C > T c.944A > G c. 1084T > G(p.Phe
362Val
c. 1193 A > C p.Y 398 C c. 1160A > G
p.(Arg407) p.Y 315 C c. 1648C > T(p.Arg
550Cys
p. Tyr 377Cys
c 17C > A(p. A6E







Severe Severe Severe Severe
Head circumference
(cm )at birth
29 29 28.5–33 29.5 30 and 26.5
Hypertonia No Yes Yes Yes Yes
Spastic quadriplegia No Yes Yes Yes Yes
Seizure Yes No 6 patients Yes Yes, both
Hyperekplexia Yes Yes Three patients No No
EEG Pattern Epileptic encephalopathy
in a transitional phase with
predominant SZ burdens
Low amplitude bilaterally














MRI Brain Microcephaly, smooth thin
cerebral cortex, simplified




























Abbreviations: M male, F female, Yrs years, EEG electroencephalography, MRI magnetic resonance image
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was added to control the abnormal movements. La-
boratory investigations (Table 2) showed normal meta-
bolic screen including plasma and CSF asparagine,
glutamine, aspartate and glutamate.CSF neurotransmit-
ters, 5HIAA, 3-OMD, and HVA were normal. Brain MRI
(Fig. 3) revealed cerebral atrophy, simplified gyral pattern
and hypoplastic cerebellum and pons. EEG showed multi-
focal discharges, fast spiking in the left hemisphere favor-
ing cortical dysplasia, and frontal spikes. The findings
favor epileptic encephalopathy in a transitional phase
with predominant seizure burdens. Whole exome se-
quence (WES) revealed nonsense mutation in the ASNS
gene, (NM_001178076.1: c.970C > T p. (Arg324*). He
died at the age of six weeks in status epilepticus.
Patient 2
Is a 4- year-old Saudi boy delivered normally at term to a
23-year-old primigravida lady and her 25-year-old first
cousin husband (Fig. 1, IV:1). Antenatal US scan revealed
microcephaly but pregnancy was uneventful otherwise.
Apgar score was 9 and 10 at one and five minutes, re-
spectively. Birth weight 2790 gm (25th percentile), length
51 cm (50th percentile) and head circumference 30 cm
(−2.6SD). He was admitted to the Neonatal Intensive Care
Unit (NICU) because of microcephaly and abnormal
movements. Clinical examination showed microcephaly,































Fig. 1 Pedigrees of the two study families. The sequence chromatograms of the mutant alleles are shown below the respective pedigrees
Fig. 2 a Photograph of patient 1 showing microcephaly,
slopingforehead, micrognathia, and relatively large ears. b Photograph
of patient 2 at age of four years. Note microcephaly, relatively large
ears, sloping forehead, and severe contractures of all limbs (spastic
quadriplegic posture)
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relatively large ears. Neurological examination revealed
tonic/clonic rapid movements of both upper and lower
limbs, with positive head retraction reflex (HRR). The
attacks were provoked by glabellar and tip of the nose tap-
ping, were non-habituating and precipitated by sounds.
Additional files 4, 5, and 6 show this in more detail.
Hypertonia with exaggerated reflexes and arthrogryposis
of both upper and lower limbs were also noted. The rest
of the systemic examination revealed no abnormality. He
was initially managed by phenobarbitone. Clonazepam
and levetiracetam were later added due to the intractable
movements. At the age of four years he was found to have
profound global developmental delay and spastic quadri-
plegia with severe contractures of both upper and lower
limbs (Fig. 2b). He also had cortical blindness and hyper-
ekplexic activities could still be elicited by glabellar and
root of the nose tapping, light and sounds [see Additional
files 1, 2, 3, 4, 5 and 6]. His growth parameters were se-
verely retarded: his weight 5.3 Kg (−6.8SD) and head cir-
cumference was 35 cm (−10.1SD).
Laboratory tests including hematologic indices, renal
function, liver function, and electrolytes were all nor-
mal. Metabolic screen, plasma amino acids, lactate, and
ammonia were unremarkable. Chromosome study re-
vealed normal male karyotype. MRI brain (Fig. 4) showed
microcephaly, thin and smooth cortex with simplified
gyral pattern [4], delayed myelination, dilatation of the
ventricles, global brain atrophy and hypoplastic cerebel-
lum and pons. EEG showed very low amplitude bilaterally
without epileptiform discharges. Only sporadic sharp tran-
sient spikes, most likely myogenic in origin, were noted.
Genetic testing, utilizing whole exome sequencing (WES),
Table 2 Biochemical findings in patient 1
Test Plasma Reference range Cerebrospinal fluid Reference range
Asparagine (μ mol/L) 55 25–91 5 0–12
Glutamine (μ mol/L) 834 316–1020 639 232–725
Glutamic acid (μ mol/L) 125 31–202 2 0–27
Aspartic acid (μ mol/L) 33 2–20 <1 0–3
CSF Neurotransmitters
5-hydoxyindoleacetic acid(5HIAA) (n mol/L) 281 Newborn (208–1159)
Homovanillic acid (HVA) (n mol/L) 410 Newborn (337–1299)
3-O-methyldopa (3-OMD) (n mol/L) 79 Newborn (0–300)
Urine organic acid Normal
Fig. 3 Brain MR images at day 1 after birth of patient 1. a Sagittal T1-weighted image showing severe microcephaly, simplified gyral pattern, thin
corpus callosum, small cerebellum, and small pons. b Axial T1-weighted image demonstrating small pons and cerebellum. c Axial T1-weighted
image showing delayed myelination of the posterior limb of internal capsule, bilaterally. d Coronal FLAIR image demonstrating severely simplified
gyral pattern and large extra-axial CSF spaces reflecting brain underdevelopment. e Proton MR Spectroscopy with long TE showing normal
spectra for age
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showed a novel homozygous ASNS gene mutation:
NM_001178076.1, missense c.944A >G, p. (Tyr315Cys).
Both parents are heterozygous carriers. This change was
absent in 615 in-house Saudi exomes, and is predicted
pathogenic by PolyPhen (0.992), SIFT (1.0) and CADD
(28.7) [5]. The family was offered genetic counselling.
We report two novel mutations in the ASNS gene in
two Saudi patients from first cousin marriages who pre-
sented with congenital microcephaly, hyperekplexia, cere-
bral atrophy, simplified gyral pattern, and hypoplastic
cerebellum and pons (Figs. 3 and 4). The phenotype is
consistent with the recently described ASNSD (OMIM#
615574). ASNS encodes an asparagine synthetase enzyme
involved in the synthesis of asparagine from glutamine
and aspartate [6]. The neurological impairment resulting
from ASNS mutation can be explained by asparagine deple-
tion in the brain or by accumulation of aspartate /glutamate
leading to enhanced excitation and neuronal damage [1].
To date five pathogenic mutations in the ASNS gene have
been identified (Table 1).
All cases of asparagine synthetase deficiency were diag-
nosed by molecular genetics as there is no reliable bio-
chemical test for diagnosing the disorder. Alfadhel et al.
[2] reported low levels of asparagine in the CSF of two sib-
lings with ASNSD confirmed by molecular genetics,
while Ruzzo et al. [1] reported low asparagine levels in
the CSF of only two of the five patients with the dis-
order. Our two patients had normal plasma and CSF
asparagine, glutamine, aspartate, and glutamate and
CSF neurotransmitters (Table 2). Therefore, this condi-
tion cannot be ruled out by normal plasma and CSF as-
paragine, aspartate and glutamate levels (Table 3) in a
patient presenting with congenital microcephaly, and
unexplained encephalopathy in the form of intractable
seizures or hyperekplexia [1].
ASNSD is a very rare disorder with a prevalence of <1/
1000000 worldwide (ORPHA 391376); and hitherto, only
12 cases have been reported. We suspect this condition is
underdiagnosed due to lack of recognition and the risk of
confusing the hyperekplexia phenotype for nonspecific
neonatal epilepsy, and also due to lack of a specific labora-
tory test and the difficulty of performing molecular gen-
etic testing in suspected cases except in research centers
or referral hospitals. Given that there is no reliable bio-
chemical test, sequencing of ASNS is the mainstay of diag-
nosis. While our two patients were diagnosed using WES,
this gene can easily be targeted by Sanger sequencing or
added to a gene panel approach as described before [7].
The clinical and radiographic presentation of our patients,
namely congenital microcephaly, hyperekplexia, brain
malformation, and (in long term survivors) severe psycho-
motor retardation and cortical blindness is identical to
that observed in the patients reported by Ruzzo et al. [1]
with ASNS gene mutation. Interestingly, we previously [8]
reported six patients with a similar presentation of hyper-
ekplexia, microcephaly and brain malformations who later
Fig. 4 MRI brain at the age of 3 weeks. a Sagittal T1-weighted image showing severe microcephaly with overlapped lambdoid sutures, brain
underdevelopment evident by simplified gyral pattern, small cerebellum, and small pons. b Axial FLAIR image revealing small pons and cerebellum.
c Axial T1-weighted image demonstrating delayed myelination evident by absent myelination of the posterior limb of internal capsule, bilaterally.
d Coronal T2-weighted image showing simplified gyral pattern (more in the frontal lobes) and large extra-axial CSF spaces due to
brain underdevelopment
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proved to have cathepsin deficiency (CTSD) known to be
associated with congenital ceroid lipofuscinosis neuronal
10 (CLN 10) [9, 10]. Our observation raises the intriguing
possibility of a link between asparagine synthetase defi-
ciency and cathepsin deficiency, although this will require
future research. Both disorders should be considered in
microcephalic neonates who present with seizures or
hyperekplexia at or before birth, and molecular genetic
testing needs to be performed for pertinent and timely
genetic counseling. This will pave the way for adopting ef-
fective preventive and therapeutic approaches like preim-
plantation genetic diagnosis (PGD), or early termination
of affected pregnancies, which helped many families in
this region with high prevalence of autosomal recessive
disorders [11]. Therapeutic approach by supplementation
with asparagine in ASNSD seems attractive. However, the
prenatal onset of the microcephaly and early postnatal
presentation make such treatment unlikely to be curative
unless started prenatally [1].
Conclusion
we expand the allelic heterogeneity of ASNSD and
emphasize the clinical homogeneity of this disorder. The
remarkable clinical overlap with CTSD-related CLN10
makes it difficult to segregate the two disorders clinically
and highlights the need for ANSN and CTSD sequen-
cing to make an accurate diagnosis.
Additional files
Additional file 1: MOV showing non-habituating glabellar and root of
the nose tapping in patient 1 (Fig. 1,V.2). (MP4 9415 kb)
Additional file 2: MOV shows exaggerated startle reflex to sounds in
patient 1 (Fig. 1,V.2). (MP4 8851 kb)
Additional file 3: MOV shows exaggerated startle reflex to light in
patient 1 (Fig. 1,V.2). (MP4 3117 kb)
Additional file 4: MOV showing non-habituating glabellar and root of
the nose tapping in patient 2 (Fig. 1IV .1), in the first week of life. (MP4
3050 kb)
Additional file 5: MOV shows exaggerated startle reflex to sound in
patient 2 (Fig. 1IV .1), at the age of 4 years. (MP4 3052 kb)
Additional file 6: MOV shows exaggerated startle reflex to light in
patient 2 (Fig. 1IV .1), at the age of 4 years. (MP4 2722 kb)
Abbreviations
3-OMD, 3-O-Methyldopa; 5HIAA, 5 hydroxy indole acetic acid; ASNS, asparagine
synthetase; ASNSD, asparagine synthetase deficiency; CLN, ceroid lipofuscinosis
neuronal; CSF, cerebrospinal fluid; CTSD, cathepsin D; EEG,
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A. Present Report (2015)
Patient 1 55 (25–91) 834 (316–1020) 33 (2–20) 125 (31–202) 5 (0–12) 639
(232–725)
<1 (0–3) 2 (0–27) Slightly Elevated
Plasma Aspartate
Patient 2 Normal Normal Normal Normal N/A N/A N/A N/A
B. Majid Alfadhel et. al (2014) [2]
Patient 1 10
(33–68.4)




N/A N/A Low Plasma and
CSF Asparagine
Patient 2 6 (33–68.4) 328 (254–823) N/A N/A 1 (1.1–6.9) 574
(356–680)
N/A N/A Low Plasma and
CSF Asparagine
C. Ruzzo el. al (2013) [1]
1 57 (23–112) 1250 (254–823) 18 (1–24) N/A N/A N/A N/A N/A High Plasma
Glutamate
2 49 (23–112) 1149 (254–823) 2 (1–24) N/A N/A N/A N/A N/A High Plasma
Glutamate
3 N/A N/A 7 (17–21) N/A N/A N/A N/A N/A Low Plasma
Aspartate
4 12 (16–21) N/A N/A N/A N/A N/A N/A N/A Low Plasma
Asparagine
5 N/A N/A 12 (0–20) N/A N/A N/A N/A N/A
6 11 (31–56) 439 (474–736) 7 (4–18) N/A N/A N/A N/A N/A Low Plasma
Asparagine
7 55 (31–56) 668 (474–736) 9 (4–18) N/A N/A N/A N/A N/A
Ben-Salem et. al (2015) Normal Normal Normal Normal N/A N/A N/A N/A
Legend: N/A Not Available
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electroencephalogram; HRR, head retraction reflex; HVA, homo vanillic acid;
IUFD, intra uterine fetal death; MRI, magnetic resonance image; NICU, neonatal
intensive care unit; PGD, preimplantation genetic diagnosis; SD, standard
deviation; US, ultrasound; WES, whole exome sequence
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